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1. Introduction  
Osteoporosis is a multifactorial disease influenced by multiple factors and characterized by 
an imbalance in the regulation of bone remodeling that cause microarchitectural 
deterioration which compromises the bone strength and leads to bone fragility increasing 
the fracture risk. Since several years ago, the World Health Organization has considered 
osteoporosis as one of the most important public health issues worldwide, with a great 
repercussion in patients’ life quality and in their familiar, social and work environments.  
Osteoporosis is an important problem in Latin America, currently its prevalence is similar to 
that in South Europe and slightly lower than in North Europe and among white population 
in the USA; World Health Organization estimates that in the forthcoming 50 years, 
osteoporosis prevalence will increase in Latin America until reach those of the currently 
observable in Europe and USA (World Health Organization [WHO], 1994; National Institute 
of Health [NIH], 2001 Consensus Development Panel on Osteoporosis Prevention, Diagnosis 
and Therapy; Cole ZA et al., 2008). During the last decades, the life expectancy has been 
increased notoriously and the number of subjects older than 60 years old has been increased. 
This situation in combination with the adverse environmental conditions and the life style, 
will cause a notorious increment in the incidence of chronic-degenerative diseases in the 
next decades, as will occur with osteoporosis. Certainly, primary osteoporosis use to be 
more frequent in posmenopausal women (Greespan  et al., 1993); however occasionally it 
appears in premenopausal women which present several risk factors and even males may 
be affected by this disorder. It is important to mention that the actual life style favours the 
inadequate bone quality of children and young people (Asociación Mexicana de 
Metabolismo Óseo y Mineral, 2001). There are two forms of osteoporosis; primary OP, 
named posmenopausal or senile form and secondary OP, which is related to diverse 
endocrine, renal, rheumatic and genetic diseases, and with the prolonged administration of 
some drugs which induce bone loss (Riggs et al., 1986; Elliot-Gibson et al., 2004).  
Discussing about osteoporosis it is necessary to mention the term “peak bone mass” (PBM), 
which refers to the maximum bone mass that an individual reaches in his life and it occurs 
between 20-30 years old approximately. PBM is the result of the interaction of multiple 
genetic and environmental factors; upon the PBM is reached, progressive loss of bone mass 
occurs naturally, depending on the magnitude and speed of subsequent bone loss (Burclar 
et al., 1989; Kanis et al., 1994; Guéguen et al., 1995.). The annual average bone loss in 
posmenopausal women is estimated in 1-2%, and 0.2.-0.5 % in males. It is considered that 
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about 30% of women at this phase shows an accelerated bone loss (approximately 5% per 
year) during the first 5 years after menopause, which represents higher risk to suffer 
osteoporotic fractures at this moment of their lives (Elliot –Gibson V et al., 2004). 
Osteoporosis has been characterized for having a very discrete clinic behavior; it is practically 
“silent” remaining latent for years or could get worsen without causing significant symptoms. 
Nevertheless, one of the most frequent clinic manifestations is the back chronic pain, which 
may be attributed to the presence of vertebral micro-fractures, frequently it can be noted 
progressive height loss due to vertebral compression and/or slimming; this anomalies can be 
heterogeneous and cause loss of the spine natural conformation causing abnormal curvatures 
and scoliosis (Ismail et al., 1999).  Fractures are the most frequent and dangerous complication 
of osteoporosis and may occur practically in all bones, even with a discrete trauma and 
spontaneously. As has been documented in LAVOS (Latín American Vertebral Osteoporosis 
Study) (Clark  et al., 2009). and EVOS (European Vertebral Osteoporosis Study) (Raspe et al., 
1998) studies, the spine is the most common site in which fracture occur. Booth studies showed 
that, the frequency of these fractures are related to gender and age, but also to races 
geographic distribution. Apparently they are more common in Scandinavian and North 
American population, whereas they are less frequent in South of Europe. Interestingly, the 
frequency is higher in urban areas than in rural ones, which outstands the importance of 
environmental factors in this disease besides of the genetic predisposition. After vertebral 
fractures, hip fractures occur, followed by forearm. It is estimated that about 25% of 
individuals showing this kind of fractures die due to complications, and other 25% (even the 
after the surgery), never recover the life quality they have before the fracture.  On the other 
hand, patients who have suffered one or more fractures (in any place) predispose to have new 
fractures, independently of their bone mineral density (BMD). The risk for new fractures is 
higher in individuals who have suffered first fractures at early age and in those who have 
higher number of previous fractures. 
2. Genetic susceptibility in osteoporosis  
There are several elements that suggest that bone phenotype is under of an important 
genetic influence. The first observation is the familial aggregation detected in the clinical 
practice, in which can be observed the segregation of some phenotypic characteristics, like 
family history of bad bone quality of osteoporotic fractures (Guéguez et al 1995; Fox et al., 
1998; Kannus  et al., 1999). On the other hand, description in literature of several diseases of 
genetic origin with monogenetic inheritance, which phenotype includes the loss or gain of 
mineral bone density, supports the hypothesis that bone phenotype has an important 
genetic component. Some of the most studied diseases are the different forms of 
osteogenesis imperfecta, the diverse varieties of osteopetrosis, pyknodisostosis, 
sclerostenosis and osteoporosis syndrome accompanied by pseudoglioma (Barros et al., 
2007), among others. Besides, there are reports of severe osteoporosis cases in which 
mutations have been detected in genes which have been previously associated with the 
genetic control of mineral bone density, as the genes for estrogens receptors 1 and 2 (ESR1, 
ESR2), androgens receptor (AR) and vitamin D receptor (VDR). Changes in the normal 
sequence of those genes could cause osteoporosis. However, the primary osteoporosis 
represents the most common form in all populations (Duncan et al., 2005, 2008, 2010). 
Primary osteoporosis has a multi-factorial and polygenic origin and the evidences that it 
shows clearly genetic susceptibility are family history of bad bone quality and fractures, 
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familial or demographic similarity during the natural history development of the disease or 
even differences in the pharmacological management response. In accordance to National 
Osteoporosis Foundation (IOF) 2008 statements, fractures family history represents an 
important risk factor independently of the bone mineral density and the presence of 
osteoporosis in first degree relatives has been related to the decrease in peak bone mass.  
The analysis of genetic susceptibility to osteoporosis has been complicated because it is  
caused by the effect of multiple genes that exert their effect on the bone phenotype, taking in 
account that a great number of environmental factors acting on BMD are involved; however, 
despite all these difficulties, a large amount and variety of worldwide investigations suggest 
that BMD heritability ranges between 40-70% in spine, between 70-85% in hip and between 
50-60% in wrist (Andrew  et al., 2005; Michaelsson et al 2005; Deng et al., 2002). 
Densitometric studies in monozygotic twins (MC) and dicygotic twins (DC) have revealed 
that spine and femoral neck BMD consistency is higher (6-8:1) in MC twins than in DC 
twins. Family studies have estimated that fractures heritability ranges between 20-60%, 
depending on the anatomic region where those occur (Michaelsson  et al 2005; MacGregor  
et al., 2000; Deng  et al., 2002). In these cases, classic segregation studies have facilitated 
identifying new genes related to the BMD genetic control.  
In the other hand, association studies have also been very helpful to associate particular 
phenotypic characteristics, such as bone mineral density or the occurrence of fractures, with 
very specific genetic variants (gene polymorphisms, specially single nucleotide variants). 
Besides, there are other bones characteristics with evident heritable component, among 
them are: geometry and length of the femoral neck, bone ultrasonic properties (which 
represent the trabecular interconnectivity degree), growth and speed of bone remodeling, 
bone dimensions and other conditions that have an impact on bone quality (Slemenda  et al., 
1996; Arden et al., 1996); for example body mass index and age at which menopause occurs. 
It is convenient to mention that family history of hip fractures has consistently been shown 
to be a risk factor for osteoporosis(Andrew et al., 2005). 
The functioning of osteoarticular system is extremely dynamic and complex, it is constantly 
under remodeling and it have multiple and varied mechanisms to maintain homeostasis; 
therefore, its genetic regulation mechanisms are also complex to understand and integrate. 
Genes that have been linked with BMD genetic control are distributed along all the human 
genome and, they are in practically all chromosomes, each of them fulfills different 
functions and contributes in a different way to the genetic control of bone phenotype 
(Stewart et al., 2006; Xiong et al., 2006; Marini et al., 2010). There are some genes with 
important roles in bone homeostasis because their products are involved in elemental 
functions related to bone structure and metabolism (formation, growth, differentiation, 
resorption, maintenance, etc.) (Ralston et al., 2002; Williams et al., 2006).  
Since long time ago, we know that bone metabolism has a great hormonal influence; therefore, 
genes that encode for its receptors are elemental in bone metabolism genetic regulation, among 
them we have genes ESR1 and ESR2 which encode for estrogens ┙ and ┚ receptors and are 
expressed in various bone cells types (osteoblasts, octeocytes and osteoclasts), both receptor 
types show a different expression pattern in the cortical and trabecular bones. Estrogens 
represent one of the most important regulators for bone metabolism, they regulate bone 
growth and maturation, and they also influence the differences between bone maturation and 
bone consolidation in men and women. These hormones have the capacity to block the 
osteoclastogenesis process, can interfere with the function of osteoclasts, induce them to 
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apoptosis, and may also modify the expression of genes involved in the bone remodeling 
process (Slemenda et al., 1996; Kameda et al., 1997; Cummings et al., 1998)). Moreover, 
hormones contribute to down the expression of the Tumoral Necrosis Factor (TNF), and 
thereby reducing osteoclasts response to the RANK and RANKL activity (the ligand binding 
to the activator receptor for the kappa B factor and its ligand) (Hughes et al., 1996). 
It is already known that vitamin D, through the interaction with its receptor, plays an 
important role in calcium homeostasis for the regulation of growth and differentiation of 
bone cells; that is the reason why the gene that encodes for the vitamin D receptor (VDR) is 
quite important in bone metabolism. Another important gene is IL6, which codifies for 
interleukin 6, which is a proinflammatory cytokine that has been related to several biologic 
processes, as bone resorption, osteoporosis and other diseases as rheumatoid arthritis, 
diabetes mellitus, cardiovascular diseases, cancer, etc. LRP5 gene, which encodes for protein 
5 related to the low density lipoprotein receptor that participates in the development and 
maintenance of several tissues and represent one of the regulators for the development and 
proliferation of the osteoblasts (Gong et al., 2001). Other genes relevant for bone metabolism 
are RANK, RANK-L and OPG which encode for key proteins for bone remodeling process 
(Capellen et al., 2002). Other genes with higher impact on bone phenotype is the COL1A1 
gene, which encodes for one of the most abundant structural proteins in bone (collagen 
1A1). A great number of investigations have analyzed the association among osteoporosis 
and allelic and genotypic variants of these genes (Ralston et al., 2002).   
There are some characteristics, for example the body mass index, that could have an impact 
on bone phenotype. These traits are also under genetic influence so we found genes that are 
related with more than one phenotype. Since several years ago it is clear that there is an 
important relation between bone mineral density and body mass, we already know that 
overweight individuals should support higher weight opposite to individuals with a lower 
body weight, therefore, bone mineral density is higher in overweight subjects, while thinner 
subjects, including the ones with alimentary disorders as anorexia or malnutrition, could 
present low bone quality. Some of the genes with impact on these phenotypes are ESR1, 
ESR2, VDR, LRP5, IL6 and OPG between others (Deng et al-. 2002; Jie et al., 2009; Frenkel et 
al., 2010)K. During the last years, the leptin gene and its receptor (LEP and LEPR) have been 
revealed as an important hormonal factors for the regulation of appetite and energetic 
metabolism; besides, leptin has an osteogenic effect by stimulating osteoblasts formation 
and plays a direct osteogenic role on bone marrow stromal cells, which allows its 
differentiation and maturation to osteoblasts (Esteppman et al., 2000). 
Other important genes in both phenotypes are the proinsulin gene (INS), its receptor (INSR), 
and probably too the gene family of growth factors similar to insulin, since apparently 
insulin exerts a mitogenic effect on osteoblasts, which could partially explain bone mass 
increment that is usually noticed in obese individuals. 
Table 1 despicts some of the genes related to the bone phenotype and the function that has 
been attributed to their products. It is evident the genetic influence on different aspects of 
metabolism and homeostasis of bone tissue (structure, formation, resorption and 
remodeling) and the number of genes involved is large and their functions are diverse. In 
the case of bone structure highlights the COL1A1 and COL1A2 genes which code for the 
type I colagen protein, which represents over 90% of the organic matrix of bone. The 
osteocalcin and osteopontin are also important, the first one is a calcium binding protein 
which is secreted by osteoblasts and is encoded by the gene OC, while the phosphoprotein 
known as osteopontin,  encoded by the gene OPN, is essential in the mineralization process. 
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Hormones and their receptors
Gene Chromosomal location Product 
ESR┙ 6q25 Estrogens receptor ┙ 
ESR┚ 14q22 Estrogens receptor ┚ 
AR Xq11 Androgens receptor 
VDR 12q12 D vitamin receptor 
PTH 11p15 Paratohormone 
PTHR1 3p22 Paratohormone receptor 1 
CT 11p15 Calcitonin 
CTR 7p21 Calcitonin receptor 
CYP1A1 15q21 Aromatase 
CASR 3q13 Receptor sensitive to calcium 
ADPN 3q27 Liponectin 
GR 5q31 Glucocorticoids receptor 
PRL 6p22 Prolactin 
LEP 7q31 Leptine 
LEPR lp31 Leptine receptor 
INS 11p15 Insulin 
INSR 19p13 Insulin receptor 
Matrix components   
COL1A1 17p21 Collagen 1A1 
COL1A2 7q22 Collagen 1A2 
OC 1q25 Osteocalcin 
OPN 4q21 Osteopontin 
With participation in 
osteoblastogenic processes 
  
ALOX12 17p13 Araquinodate 12 lipoxigenase 
ALOX15 17p13 Araquinodate 15 lipoxigenase 
BMP2 20p12 Morphogenetic protein of bone 2 
BMP4 14q22 Morphogenetic protein of bone 4 
BMP7 20q13 Morphogenetic protein of bone 7 
IGF-1 12q22 Growth factor similar to insulin 
LRP5 11q13 
Receptor related to lipoprotein 
of low density 5 
LRP6 12p13 
Receptor related to lipoprotein 
of low density 6 
SOST 17q12 Sclerotin 
NOG 17q22 
Protein antagonist of 
morphogenetic proteins 
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With participation in 
osteoclastogenesis processes
  
Gene Chromosomal location Product 
P53 17p13 Tumor suppressor P53 protein 
CPK 1q21 Catepsine K
OC 1q25 Osteocalcin
OPN 4q21 Osteopontin
OPG 8q24 Osteoprogeterin
RANK 18q22 
Receptor activator of NF-
KAPPA-B  
RANK-L 13q14 
Ligand of the receptor activator 
of NF-KAPPA-B
CLC7 16p13 Chlorine channel 7
Cytokines and their receptors
IL1┙ 2q14 Interleukin 1A
IL1┚ 2q14 Interleukin 1B
IL6 7p21 Interleukin 6
TNF 6p21 Tumoral necrosis factor 
TNFR2 1p36 
Tumoral necrosis factor receptor 
2
Others functions  
MTHFR 1p36 
5,10-Methylenetetrahydrofolate 
reductase
APOE1 19q13 Apolipoprotein E
MMP-1 11q22 Metalloproteinase
MMP-2 16q13 Metalloproteinase 
MMP-9 20q11 Collagenase
PON-1 7q21 Esterase
SHH 7q36 
Hedgehog protein 
(it participates in skeleton 
embryogenesis)
Table 1. Genes related to bone phenotype, their chromosomal location and their products 
The osteoclastogenesis and the osteoblastogenesis are fundamental processes for the 
homeostasis of bone tissue as the speed and intensity of bone formation and bone resorption 
depending on several conditions. Both mechanisms show a significant genetic influence, so 
the amount of genes and therefore of proteins with participation in both processes is very 
significant. Among them are genes that encode for the family of bone morphogenetic 
proteins (BMP´s), the LRP5 and LRP6 genes that code for receptors for low density 
lipoproteins, which are involved in the osteoblastogenesis most likely to regulate the level of 
bone mineralization. The osteoclastogenesis is determined by the differential expression of 
genes of the RANK/RANK-L/OPG route. The P53 oncogene which product is very 
important for multiple biological processes and the cathepsin K gen (CPK) wich codes for a 
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collagenase with preferential expression in osteoblasts, indubitably play a crucial role in 
bone resorption.  
Different hormones involved in the bone formation and remodeling, including the sex 
hormones (estrogen, progesterone, androgens), growth hormone, insulin, parathyroid 
hormone, calcitonin, cortisol and thyroid hormones. These hormones are implicated in 
different ways in bone metabolism according to the different stages, including intrauterine life, 
in such a way that the different hormones impact on linear growth of bones, bone maturation, 
bone homeostasis and the size that will be achieved in adulthood. That's why there are 
hormonal conditions such as hypothyroidism, hyperthyroidism, postmenopause, andropause 
and glucocorticoid prolonged intake which are capable to impact on the quality of the bone. 
Finally we can not ignore that various interleukins, growth factors and their receptors have 
been identified and the participation in the genetic control of bone mineral density of other 
proteins are still under study, as in the case of IL┙, IL┚, IL6, TNF, TNFR2 among others. 
On the other hand, it is important to mention that during the last years some investigations 
have pointed out that some of the genes related with bone phenotype have been related to 
other disorders as cardiovascular diseases; for example, genes such as osteoprotegerin 
(OPG), the receptor activator for nuclear factor kappa B ligand (RANKL) and bone  
morphogenetic protein 2 (BMP) have been associated with osteoporosis and with 
cardiovascular diseases, particularly atherosclerosis, which suggest that products of these 
genes take part in the calcification process (Collin-Osdoby et al., 2004; Marini et al., 2010). 
3. Linkage analysis as strategy in the study of osteoporosis 
Linkage studies are well validated for identification of responsible genes in monogenic 
diseases, since the inheritance of marker alleles is related to the inheritance of a bone trait 
within family members. Combining the use of statistical approaches in quantitative trait loci 
(QTL) and genome-wide association studies (GWAS), it is possible to establish a strategy to 
identify chromosomal regions which contain regulating genes of some important traits in 
complex polygenic diseases with genetically heterogeneous traits as osteoporosis, making 
possible to evaluate how many of the hundreds of proposed candidate genes are really 
associated. Most of linkage studies in osteoporosis selected the bone mineral density as the 
trait of interest; however regions that regulate other relevant phenotypes, such as bone mass 
and skeletal geometry, have been investigated. 
Former studies identified important loci linked to bone mass and geometry. A genome 
search study in sib pairs recruited from families with a history of osteoporosis, obtained 
data suggestive of linkage of 1p36, 2p23-24 and 4q32-34 with spine and hip BMD (Devoto et 
al., 1998; Devoto et al., 2001). Studies with healthy female sib pairs demonstrated linkage of 
locus 11q12-13 with BMD variation (Koller et al., 1998) and evidence suggestive of linkage of 
1q21-23, 5q33-35 and 6p1-12 to femoral neck or lumbar spine BMD was obtained in a 
genome-wide search study performed in Caucasian and African-American healthy female 
sib pairs (Koller  et al., 2000). Other study identified loci in 5q and 4q that showed linkage to 
regulation of important aspects of femoral neck geometry (Koller et al., 2001). A QTL not 
previously described in 22q11 showed suggestive linkage in a study with families from 
Belgium and France (Kaufman et al., 2008). The presence of genes controlling BMD on 1p36 
was suggested too in a multivariate linkage analysis in osteoporosis pedigrees (Zhang et al., 
2009). One genome-wide scan for bone loss showed that change in femoral neck BMD in 
Mexican-American families is significantly linked to 1q23 (Shaffer et al., 2009). Interestingly 
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a study with pairs of brothers suggested that QTL on 7q34, 14q32 and 21q21 were male-
specific (Peacock et al., 2009) and other report provides evidence of gender specific QTL on 
10q21 and 18p11 (Ralston et al., 2005). Suggestive evidence of linkage of novel regions 
related with BMD and hip geometry on chromosomes 4, 5, 11, 16 and 20 was obtained in a 
sample of Caucasian Europeans (Karasik et al., 2010).  
Two important large scale studies with a cohort of more than 19,000 european subjects, 
identified SNPs in previously proposed osteoporosis candidate genes and in regions not 
previously associated with femoral neck and lumbar spine BMD. SNPs from ESR1, LRP4, 
ITGA1, LRP5, SOST, SPP1, TNFRSF11A, TNFRSF11B AND TNFSN11 associated with either 
femoral neck or lumbar spine BMD in a cohort of more than 19,000 subjects. In the same study, 
SNPs from LRP5, SOST, SPP1 and TNFSF11A, were associated with fracture risk (Richards et 
al., 2009). The other study, confirmed the significant association of previously known BMD 
loci: ESR1, TNFRSF11B, LRP5, SP7, ZBTB40, TNFSF11 and TNFRSF11A, but interestingly they 
identified several loci in regions not previously associated with BMD (Rivadeneira et al., 2009). 
Recently, variants in CATSPERB (Koller et al., 2010), MATN3, IGF1 (Li et al., 2011), SOD2 
(Deng et al., 2011) and FONG (Kou et al., 2011) genes between many others, have been 
involved in BMD regulation and in the pathogenesis of osteoporosis. Evidences for genes or 
loci association with BMD are controversial in many cases (Ralston & Uterlinden, 2010). 
Further large scale studies will be necessary to address the role of gene variants on BMD and 
osteoporosis, but the importance of this studies lies in the potential uses and clinical 
implications since, besides of differences in the effect of variants, the identified genes might be 
important for drugs design to prevention and treatment of osteoporosis. 
4. Association studies 
During the last years, association studies among natural variations of our genome (gene 
polymorphisms) and particular phenotypic characteristics such as OP, have shown that the 
mechanisms that condition this heritable susceptibility are defined by the presence of 
mutations or polymorphisms in one or several genes that influence bone phenotype. In this 
case, it is important clarifying that the term polymorphism refers to the presence of two or 
more gene variants in the same allele, in such a way that the less common variant must have a 
frequency equal or higher on 1% of the population, otherwise, the variation is considered as a 
mutation. These changes in the normal sequence may involve several bases, as in case mini-
satellites or VNTR (variable number of tandem repeat), where the size of repeated fragments 
range from 15 to 70 pairs of bases in tandem. Other kind of polymorphisms are of micro-
satellite also known as STR (short tandem repeats), which characterize for showing variations in 
the nucleotide number (2-6 base pairs). Recently, single nucleotide variations also known as 
SNPs (single nucleotide polymorphisms) have been analyzed; in this case, the analysis of these 
variations represents a very commonly used tool in studies that intend associating certain 
allelic variants with phenotypic characteristics, specially the ones attributed to polygenic 
diseases (multi-factorial and complex). Table 2 shows several single nucleotide 
polymorphisms studied in relation to osteoporosis and bone mineral density. It can be 
observed that some polymorphisms have been consistently studied with respect to particular 
bone traits, such as BMD in specific anatomic regions and in some cases with fracture risk. 
Polymorphisms in genes as ER ┙ and ┚, IL6, VDR, Aromatase (CYP19), COL IA1, RANK 
and RANKL are between the most studied. There are several polymorphic sites which 
association with BMD or with osteoporosis has been demonstrated in many different 
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populations. The results in many cases have been controversial, for example the SNP G/A 
in ER┙ gene exon 8, have been associated with osteoporosis in Thailander 
(Ongphiphadhanakul et al., 2001) and in Mexican women (Gómez et al., 2007), but 
association was denied when it was studied in Spanish women (Riancho et al., 2006), in 
spite all three investigations were performed with posmenopausal women. The T/C SNP of 
ER┙ gene was associated with low BMD in Japanese women, but not in Afro-American, 
Caucasian or Chineese women and the A/G SNP of the same gene, was associated with low 
BMD only in Afro-American Women, but not in Caucasian, Chinese nor in Japanese women 
(Greendale et al., 2006). The differences between studies results might be due to the genetic 
background of studied populations, which emphasize the importance of performing studies 
to explore the polymorphisms in specific groups with the same characteristics to avoid the 
incorrect use of genetic markers. Differences between races were evident too in studies with 
the IL6 G572C polymorphism in which the results in Korean (Chung et al., 2003) and 
Japanese (Ota et al., 2001) populations were consistent associating the G allele with low 
BMD, meanwhile in the study performed with Caucasian US women (Ferrari et al., 2003), 
the G allele appears as a protective factor from bone resorption. 
Discordances can certainly be seen due to the frequencies of some alleles in different 
populations. It is important to determine the frequency of the polymorphism in a general 
population study before to perform a case-control study, since some genetic sites could be 
not polymorphic in some populations or the variant might be present in very low 
frequencies and their analysis could give spurious or no association results. An example of a 
SNPs which could not be used as osteoporosis genetic markers in Korean population are the 
G174C and G/A polymorphisms in the promoter of the IL6 gene because they show a very 
low frequency of this polymorphisms which difficult to found associations (Chung et al., 
2003). However, the same G174C SNP was analyzed in Caucasian American healthy women 
(Ferrari et al., 2003) and in Mexican osteoporotic and non osteoporotic women as well as in 
general population (Magaña, et al., 2008), obtaining that the C allele is a protective factor 
from bone resorption and from osteoporosis respectively. However, most of the VDR gene 
SNPs showed in table 2, were consistently associated with low BMD or with osteoporosis in 
a great variety of populations. SNPs in intron 10, exon 2 and promoter of the gene, have 
resulted associated in European (Bustamante et al., 2007b; Utterlinden et al., 2001) American 
(Kiel et al., 2007; Pérez et al., 2008; Moffet et al., 2007) and Asiatic (Mencej et al., 2009) 
populations and even in large scale studies with world´s population (Morrison, 2004). The 
colagen IA1 is one of the most studied genes involved in osteoporosis. Many SNPs have 
been consistently associated with BMD and osteoporosis in several populations in this gene. 
The G/T change has been associated with osteoporosis in almost all studied populations, for 
example in Mexican (Falcón-Ramírez et al., 20011) and in British (Stewart et al., 2006). Not 
all the polymorphisms have a functional effect on bone traits, but the presence of the 
polymorphism G/T in Sp1 site, alters the recognition of the Sp1 factor having effects on 
transcription, protein production and mechanical strength of bone. 
The appropriate expression of the genes of the route of signaling RANK/RANK-L/OPG is 
essential in osteoclastogenesis process, and makes them some of the most investigated genes 
performing studies with specific allelic, genotypic and haplotypic variants in this genes 
searching for associations with bone mineral density. In this case, variations of a single 
nucleotide in the intron 1, 9, and others located in the 3´del region gene RANK have 
consistently shown their association with low bone mineral density in spine and hip in 
European populations (Paternoster et al., 2010; Styrkarsdottir et al., 2009, Xiong et al., 2006). 
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Ichikawa et al., 2005. Associated with spine BMD norm
and women.
IL-6 G/C
(G572C)
Promoter Chung et al., 2003.
Ota et al., 2001.
Ferrari et al., 2003
Magaña et al., 2008.
C allele and increased BMD in pr
G allele associated with low BMD
women
G allele as protective factor from
Caucasian US women older than
w
w
w
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IL-6 G/C
(G174C)
Promoter Chung et al., 2003.
Ferrari et al., 2003.
Magaña et al., 2008.
No association with BMD of Kor
its low frequency among Korean
The C allele as a protective factor
Caucasian US women older than
The C allele is associated as a pro
G/A Promoter Chung et al., 2003. Korean premenopausal women. 
low frequency among Korean po
IL6R C/T
G/A
A/C
Promoter
Promoter
Exon 9
Bustamante et al., 2007a. C/T and G/A polymorphisms as
body mass ratio; A/C associated
postmenopausal women.
VDR C/T 3' UTR Kiel et al., 2007.
Bustamante et al., 2007b.
Associated with low BMD of fem
population (Framingham).
Associated with low BMD in Spa
A/C Intron 10 Kiel et al., 2007.
Morrison, 2004.
Associated with low BMD femor
(Framingham).
Associated with low BMD. World
A/C Intron 10 Bustamante et al., 2007b.
Uitterlinden et al., 2001.
Associated with low BMD in Spa
Not associated with BMD or fract
population.
A/G Intron 10 Kiel et al., 2007.
Bustamante et al., 2007b.
Morrison, 2004.
Pérez et al., 2008.
Associated with osteoporosis and
US population (Framingham).
Associated with low BMD in Spa
Associated with osteoporosis. W
Low BMD in spine and/or femor
menopausal Argentinean women
C/T Exon 2 Bustamante et al., 2007b.
Pérez et al., 2008.
Associated with BMD; not clearly
Low BMD in spine and/or femor
menopausal Argentinean women
A/C/G/T Exon 2 Kiel et al., 2007.
Morrison, 2004.
Moffett et al., 2007.
Associated with osteoporosis and
US population (Framingham).
Associated with osteoporosis. W
C/C genotype Associated with lo
Caucasian postmenopausal US wo
w
w
w
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VDR C/T Exon 2 Uitterlinden et al., 2001. Associated with a larger number
significant differences as risk fact
women.
A/G Promoter Kiel et al., 2007.
Morrison, 2004.
Mencej et al., 2009.
Associated with osteoporosis and
US population (Framingham).
Associated with osteoporosis. W
Associated with osteoporosis in S
A/G Promoter 
region
Uitterlinden et al., 2001. Associated with fractures but not
A/C rs2189480 Kiel et al., 2007.
Bustamante et al., 2007b.
Associated with low BMD of fem
population (Framingham).
Associated with low BMD of fem
postmenopausal Spanish women.
CYP19 ins/del TTC Intron 4 Limer et al., 2009.
Riancho et al., 2005.
Mendoza et al., 2006.
Low heel BMD with 1 or 2 copies
countries.
Low hip and spine BMD with TTC
Low hip and spine BMD with TTC
T/C Exon 3 Riancho et al., 2007.
Riancho et al., 2009.
Associated with higher vertebral
Associated with low hip and spin
women. 
C/T 3'  UTR Limer et al., 2009.
Mendoza et al., 2006.
Low heel BMD in males of many
Low hip and spine BMD in Spani
C/G 5' UTR Riancho et al., 2007.
Riancho et al., 2009.
Associated with vertebral fracture
Higher hip BMD with GG genoty
C/T Exon I.6 Riancho et al., 2009. Associated with high hip BMD wi
A/G Between 
exons 
I.2   y   I.6
Riancho et al., 2007. Associated with vertebral fractur
C/G
G/A
3' UTR
Intron 2
Kiel et al., 2007. Associated with osteoporosis  an
of European origin (Framingham
C/T 3' UTR Xiong et al., 2006. Associated with hip/spine osteop
T/C 
C/T
Intron 8
Intron 2
Xiong et al., 2006. Associated with hip/spine osteop
families.
w
w
w
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CYP19 T/C
G/A
C/T
Intron 3
Intron 4
Intron 5
Hong et al., 2007. Associated with low (T/C)  and  
Chinese men.
PTHR1 A/T
C/T
A/G
T/C
Intron 1 
Intron 2
 Intron 8 
Intron 10
Vilariño-Güell et al., 2007. As haplotype, they are associated
and/or loss of BMD in spine and
(FAMOS), in Caucasian  and  Brit
OPG  G/A 3' UTR Richards et al., 2008.
Paternoster et al., 2010.
Associated with low BMD in spin
(Rotterdam study).
Associated with low BMD cortica
Kingdom (ALSPAC) and Swedish
G/C Exon 1 García-Unzueta et al., 2008.
 Kim et al., 2008.
Lee et al., 2010.
High BMD with CC genotype in S
High BMD with CC genotype; do
women.
Low spine BMD in European and
A/G 5' proximal 
region
Geng et al., 2007. BMD high con AA genotype in C
ITGA1 C/T
T/G
A/C
Exon 3
Intron 5
Intron 28
Lee et al., 2007. Associated as alleles and also as ha
Korean women.
COLIA1 G/T Intron 1 Stewart et al., 2006.
Jin et al., 2009.
Falcón-Ramírez et al., 2011.
Low BMD with haplotype -1997G
spine in British women.
Low BMD and increment of fract
women.
Associated with spine osteoporo
G/T Promoter Stewart et al., 2006. Low BMD in hip and spine of Bri
haplotype with other SNPs of the
Ins/del T Promoter Stewart et al., 2006.
Jin et al., 2009.
Low BMD in hip and spine in Bri
Low BMD and increment of hip f
women.
C/A  Intron 11 Kiel et al., 2007. Associated with the width of the fe
w
w
w
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RUNX2  A/T
A/T
T/C
Intron 3
Intron 4
Intron 4
Ermakov et al., 2006. Associated with anthropometric 
in Israel.
C/T Promoter 2 Lee et al., 2009. CC genotype shows a low BMD i
in spine and hip.
A/G Exon 2 Vaughan et al., 2002. The A allele was associated with a
women.
Unknown 
gene
G/T
A/G
rs6696981
rs7524102
Styrkarsdottir et al., 2008. Associated with hip and spine fra
Danish women.
RANK rs3018362 Paternoster et al., 2010.
Styrkarsdottir et al., 2009.
Associated with low cortical BMD
Kingdom (ALSPAC) and Swedish
Associated with low BMD in hip o
A/G
A/G
A/C
C/G
A/G 
A/G
A/T
G/T
A/T
C/T
A/G
G/T
G/T
C/T
C/G
G/T
C/T
Intron 1
Intron 1
Intron 1
Intron 1
Intron 1
Intron 2
Intron 3
Intron 3
Intron 4
Intron 7
Intron 7
Intron 9
Intron 9
Intron 9
Intron 9
3' region
3' region
Xiong et al., 2006. Analyzed as haplotypes, these 17
association with osteoporosis an
in European families.
A/G Intron 6 Koh et al., 2007. Polymorphism associated with lo
trocanter and femur, in Korean p
w
w
w
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RANKL C/T Intron 1 Xiong et al., 2006.
Mencej et al., 2006.
Mencej et al., 2008.
Mencej et al., 2009
Associated with hip BMD decreas
CC genotype Associated with a l
Slovenia women.
Associated with low spine BMD in
Associated with spine BMD decre
women.
C/T Intron 2 Xiong et al., 2006. Associated with hip BMD decreas
C/T Intron 1 Mencej et al., 2006.
Mencej et al., 2008.
CC genotype associated with low
postmenopausal Slovenia wome
Association to low spine BMD of
C/G Intron 1 Mencej et al., 2008. Associated with a BMD decrease i
Slovenia women.
C/T
C/T
rs9594738 
rs9594759
Styrkarsdottir et al., 2008. Associated with low spine BMD a
fractures, in Australian, Danish a
HDC C/T
A/C
A/C
C/T
3' region
3' region
5' region
5' region
Xiong et al., 2006. Polymorphisms associated with h
families.
ADCY10 G/A Exon 7 Ichikawa et al., 2009. Positive association to spine BMD
spine of US population (sisters st
C/T Intron 14 Ichikawa et al., 2009. US men presented association to hi
spine BMD.
TWIST1 A/G 3' region Hwang et al., 2010. Associated with osteoporosis in p
Table 2. Gene polymorphisms associated with osteoporosis and bone mineral density. 
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Other variations of a single nucleotide in intron 1 of the RANK-L gene have repeatedly been 
associated with low BMD of hip and spine in European, Asiatic and European populations 
(Xiong et al., 2006; Mencej et al., 2006; Mencej et al., 2008; Styrkarsdottir et al., 2008). The 
presence of these polymorphisms on human genome, are relatively easy to identify since 
birth or even in prenatal stage. These polymorphisms show a well defined inheritance 
pattern and their distribution may show differences not only among family groups but 
among populations and ethnic groups. However, in this kind of studies, we must be 
extremely careful and constantly consider the potentially confusing effect of some variables, 
such as: heterogeneity of populations, caused by genetic admixture, specially product of 
population's migration, the number of individuals included in studies is very important as 
well as the proper selection of cases and controls, and finally, the method to analyze data 
(Spencer et al., 2009; Duncan et al., 2002; Macarty et al., 2008). Not considering these 
elements in association studies would easily led us to establish spurious associations (Koller 
et al., 2004). Defining the genetic basis of primary osteoporosis in any population is not a 
simple task, we face a multi-factorial and polygenic entity present in populations that may 
have a great genetic heterogeneity; however the exploration of bone structure and 
metabolism genetic control, would allow to know the molecular basis of diseases such as 
osteoporosis, which represents a new window to explore therapeutic opportunities that 
would facilitate management of bone disorders. 
5. Epigenetics and osteoporosis 
During the last years attempts have been made to analyze the relation between 
environmental and genetic factors in the so called "complex diseases" using epigenetic 
studies. Epigenetics studies causal interactions among “genes” and their “products” which 
give place to the “phenotype”, which represents the body manifestation of a specific genetic 
profile. Epigenetics analyzes hereditary changes in the gene expression without changes in 
the DNA sequence, thus representing an important nexus between genotype, environment 
and the presence of a disease (Dupont et al., 2009). In osteoporosis, as a polygenic entity in 
which environmental component plays a determinant role, several risk conditions of 
maternal origin as bad nutrition of the mother, particularly the lack of vitamin D, habits as 
smoking and exposition to chemical agents (possibly including some drugs that impact bone 
quality), have the capacity to induce hereditary changes on future generations, which may 
occur in very early stages of the embrionary development, even during the neonatal period 
and they can generate an “imprinting” in the pattern of gene expression; this pattern is 
hereditary and “semi-permanent” because epigenetic modifications are reversible (Jiang et 
al., 2004; Dupont et al., 2009). On the other hand, apparently there is a relationship between 
low weight and size at time of birth and a higher risk of osteoporotic fractures during adult 
stage. Then we should understand that besides genetic and environmental factors, 
“epigenetic” can influence genome expression, so the prevention of some maternal 
conditions represents a valuable opportunity to develop preventative strategies aimed to 
improve bone quality in future generations.  
6. Conclusion 
Increment in life expectancy in some populations, ageing, changes in life style, especially the 
ones related to nutrition quality and physical activity, plus the vertiginous technological 
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development are characteristics of modern civilizations. This fact generates without a doubt 
a glaring increment in the incidence of several chronic degenerative diseases which may 
become crippling as occurs with osteoporosis, where the complications directly or indirectly 
cause great social and economic costs; thereby, they represent a social and health services 
challenge. Considering environment effects on the bone phenotype and the modifications in 
life style of populations in present time, osteoporosis could be in the future a disorder that 
occurs in younger population, rather than preferentially in elder people. This situation could 
overpass the medical services answer capacity and the governmental budget assigned to the 
medical care and rehabilitation of these patients; so it is important to intensify the 
investigations leading to elucidate the physiopathology of this disorder and the most 
relevant processes in bone metabolism.  
Genetic association studies enable identification of new genes related to bone metabolism. 
Knowledge of the function of its products will allow us attaining a better understanding of 
some aspects of bone metabolism not entirely explored yet and will open new opportunities 
for therapeutic development in osteoporosis. On the other hand, clinical research from 
which results association studies, makes possible to identify and associate genotypic profiles 
(haplotypes) of risk in families and populations and even in ethnic groups. There is no 
doubt that progress in this scientific knowledge field, technological progress and especially 
the various preventative strategies at different stages of life, including prenatal stage 
through the integral care of maternal health, will surely contribute to achieve a better 
understanding of the disease, a better care and especially a better prevention.     
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